Seoul, South Korea

Jun-Gyo Oh

This inventor holds 1 USPTO granted patent. Top assignee: Dong-A Pharmaceutical Co., Ltd. Active years: 2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jun-Gyo Oh. Retrieved from https://idiyas.com/inventor/jun-gyo-oh

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 17(Granted Patents)


Company Filing History:


Years Active: 2002

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jun-Gyo Oh: Innovator in Pharmaceutical Solutions

Introduction

Jun-Gyo Oh is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in enhancing the solubility of drugs. His innovative approach has led to advancements that benefit oral administration of medications.

Latest Patents

Jun-Gyo Oh holds a patent for "Intraconazole exhibiting an improved solubility, a method of preparing the same and a pharmaceutical composition for oral administration comprising the same." This patent focuses on reducing the particle diameter of itraconazole, an insoluble drug, and transforming its crystallinity from crystalline to amorphous. This transformation significantly increases the water solubility and dissolution rate of the drug, making it more effective for oral administration.

Career Highlights

Oh is currently associated with Dong-A Pharmaceutical Co., Ltd., where he continues to work on innovative pharmaceutical solutions. His expertise in drug formulation and development has positioned him as a key player in the industry.

Collaborations

He has collaborated with notable colleagues, including Bong-Jin Cha and Su-Eon Kim, to further enhance the research and development efforts at his company.

Conclusion

Jun-Gyo Oh's contributions to pharmaceutical innovations demonstrate his commitment to improving drug efficacy and patient outcomes. His work continues to influence the field positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…